Variant report
Variant | nsv889964 |
---|---|
Chromosome Location | chr8:4501278-4514076 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7009980 | chr8:4501278-4501279 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs144965916 | chr8:4501299-4501300 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs183439282 | chr8:4501303-4501304 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs376208254 | chr8:4501322-4501323 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs116279227 | chr8:4501327-4501328 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs528377271 | chr8:4501347-4501348 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs547383292 | chr8:4501350-4501351 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs186309046 | chr8:4501353-4501354 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs533237144 | chr8:4501363-4501364 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs551488190 | chr8:4501368-4501369 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs570074997 | chr8:4501403-4501404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs112381241 | chr8:4501405-4501406 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs368901494 | chr8:4501419-4501420 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs113859623 | chr8:4501424-4501425 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs191154197 | chr8:4501432-4501433 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs567904003 | chr8:4501469-4501470 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs182121869 | chr8:4501493-4501494 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs548438014 | chr8:4501494-4501495 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs186557462 | chr8:4501495-4501496 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs373100149 | chr8:4501502-4501503 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs552997635 | chr8:4501505-4501506 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs577739474 | chr8:4501517-4501518 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs538657456 | chr8:4501518-4501519 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs78507621 | chr8:4501532-4501533 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs556981818 | chr8:4501552-4501553 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs7001148 | chr8:4501563-4501564 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs192558953 | chr8:4501570-4501571 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs560970826 | chr8:4501576-4501577 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs76908619 | chr8:4501578-4501579 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs188670658 | chr8:4501584-4501585 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs192884836 | chr8:4501587-4501588 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs185023000 | chr8:4501600-4501601 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs146797627 | chr8:4501606-4501607 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs569648841 | chr8:4501616-4501617 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs80036584 | chr8:4501622-4501623 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs148952489 | chr8:4501626-4501627 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs143735224 | chr8:4501631-4501632 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs532257116 | chr8:4501650-4501651 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs567806537 | chr8:4501679-4501680 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs558597395 | chr8:4501686-4501687 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs7014444 | chr8:4501691-4501692 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs189487469 | chr8:4501711-4501712 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs538593862 | chr8:4501747-4501748 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs2725005 | chr8:4501774-4501775 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs575290202 | chr8:4501797-4501798 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs536008367 | chr8:4501808-4501809 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs2169740 | chr8:4501823-4501824 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs191685966 | chr8:4501825-4501826 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs554884803 | chr8:4501826-4501827 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs572735808 | chr8:4501835-4501836 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Colorectal cancer | 22014273 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:4496600-4501400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr8:4498200-4501400 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
3 | chr8:4498600-4501800 | Enhancers | Fetal Lung | lung |
4 | chr8:4499600-4502000 | Enhancers | Cortex derived primary cultured neurospheres | brain |
5 | chr8:4500200-4501400 | Weak transcription | Fetal Muscle Leg | muscle |
6 | chr8:4501400-4501600 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
7 | chr8:4501400-4501800 | Enhancers | Fetal Muscle Leg | muscle |
8 | chr8:4501400-4502200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
9 | chr8:4501600-4502000 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
10 | chr8:4501800-4502000 | Enhancers | Fetal Kidney | kidney |
11 | chr8:4501800-4503000 | Weak transcription | Fetal Muscle Leg | muscle |
12 | chr8:4502000-4502400 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
13 | chr8:4502000-4503200 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
14 | chr8:4502400-4503200 | Enhancers | Cortex derived primary cultured neurospheres | brain |
15 | chr8:4502600-4502800 | Enhancers | Fetal Kidney | kidney |
16 | chr8:4503000-4503200 | Enhancers | Fetal Muscle Leg | muscle |
17 | chr8:4503200-4508800 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
18 | chr8:4508800-4510000 | Enhancers | Cortex derived primary cultured neurospheres | brain |
19 | chr8:4509600-4510600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
20 | chr8:4510000-4510600 | Enhancers | H1 Cell Line | embryonic stem cell |
21 | chr8:4510000-4510600 | Active TSS | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
22 | chr8:4510200-4510800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
23 | chr8:4510600-4514400 | Weak transcription | H1 Cell Line | embryonic stem cell |
24 | chr8:4511400-4511600 | Enhancers | Adipose Nuclei | Adipose |
25 | chr8:4511600-4512000 | Flanking Active TSS | Adipose Nuclei | Adipose |
26 | chr8:4512000-4512200 | Enhancers | Adipose Nuclei | Adipose |